Das amerikanische 3D Biotechnologie Unternehmen Organovo Holdings Inc. (ONVO), handelt seine Anteile nun an der New York Stock Exchange (NYSE)
Die Stammaktien des Unternehmens wurden am 09.07.2103 an der NYSE MKT gelistet und werden dort seit dem 11.07.2013 unter dem Kürzel ONVO gehandelt. Der neue Handelsplatz ersetzt den bisherigen “over-the-counter” Finanzmarktplatz OTCQX.
Organovo To List Common Stock On New York Stock Exchange MKT07/09/2013
SAN DIEGO, July 9, 2013 /PRNewswire/ — Organovo Holdings, Inc. (OTCQX: ONVO), a biotechnology company focused on delivering breakthrough three-dimensional (3D) bioprinting technology, is pleased to announce that its common shares have been approved to list on the NYSE MKT and will begin trading on the New York Stock Exchange on July 11, 2013. The Company will continue to trade under the symbol “ONVO” but will withdraw its shares from listing on the OTC QX concurrent with listing its shares on the NYSE MKT, the premier US equities market for listing and trading of small growth companies.
“Trading on the New York Stock Exchange is an important milestone forOrganovo and will be valuable to our business and shareholders. Our decision to move to the NYSE MKT was based on a firm belief that the exchange offers the best set of conditions for Organovo’s success, and thus the best opportunity to add value for our shareholders,” said Keith Murphy, President and CEO ofOrganovo Holdings, Inc.. “We found NYSE to have made an unparalleled commitment to providing a fertile platform for growth to early stage biotechnology companies, and we look forward to a great future on the exchange.”
NYSE MKT is a fully integrated trading venue within the NYSE Euronextcommunity and leverages the NYSE’s advanced and innovative market model to offer a premier venue for listing and trading the stocks of small companies. The venue utilizes the trading, connectivity and routing technologies of the NYSEplatform and offers superior price discovery, superior liquidity and reduced trading volatility. Listed companies benefit from issuer-selected Designated Market Makers (DMM) that utilize world-class NYSE trading systems to discover and improve prices, dampen volatility, add liquidity and enhance value. In addition, NYSE MKT-listed companies gain access to the brand visibility and are eligible for the issuer services enjoyed by the NYSE Euronext community.
“We welcome Organovo to the NYSE MKT family of listed companies,” said Scott Cutler, Executive Vice President, Global Listings at NYSE Euronext. “Organovowill be joining other growth oriented companies in the U.S. taking advantage of the NYSE’s advanced and innovative market model to offer a premier value for listing and trading their stocks.”